Investing in Innovation
Parkwalk invests in innovative UK growth companies across various stages of their development. The Funds seek capital appreciation, with the added advantages to investors of the tax reliefs offered under the Enterprise Investment Scheme.
Each Parkwalk Fund invests in a minimum of five companies, and investee companies range from early stage through to AIM-listed, creating a diverse portfolio of sectors and business development stages with capital raised used for development, commercialisation and expansion through to acquisition capital.
The Funds invest in companies whose proprietary IP or know-how originated from UK R&D intensive institutions and Universities, enabling the Funds to participate in the fruits of some of Britain’s c.£4.5bn publicly-funded research.
In under four years, both the Parkwalk UK Technology Funds I & II have each separately returned, in cash, more to investors than the total cost of their subscriptions into each Fund, and each Fund still contains current portfolio companies with the potential to offer further returns to investors as the investee companies mature. Funds III, IV, V and the Opportunities Fund have all also had cash distributions from a successful exit.
Parkwalk EIS Funds
As at Q1 2017, Parkwalk have achieved two highly successful trade sales and three Parkwalk portfolio companies had successfully listed their shares on the Alternative Investment Market of the London Stock Exchange (AIM) – Revolymer, Horizon Discovery and Xeros.
Parkwalk first invested in Xeros in October 2010, at 33.0p per share equivalent (26.4p net of initial tax relief). In September 2014 we part-exited for the UK Tech Fund I, returning to investors more than the total cost of their investment in the Fund in under four years. We remain a substantial shareholder in Xeros for later investments through our Syndicates and Opportunities Fund.
Parkwalk invested in Revolymer in April 2011, and the company successfully raised £25m when it listed on AIM in July 2012 at a small uplift to our original investment level.
Parkwalk invested in Horizon Discovery in May 2013. The company had a hugely successful IPO in March 2014, raising £40m to list with a market capitalistion of £120m. The floatation was priced at over 100% above the price at which Parkwalk invested.
- 30% Upfront Income Tax Relief
- Tax-Free Capital Gains
- Loss Relief of up to 61.5% for a 45% taxpayer
- IHT Exemption after 2 years
Parkwalk UK Tech Funds have been positively reviewed by both the ‘Tax Efficient Review’ and the ‘Tax Shelter Report’. Please click here to email the funds team to request a copy of these reviews.
As of Q1 2016, Parkwalk UK Tech Funds I-V are approximately invested 50% in seed/series ‘A’ and 50% in series ‘B’, ‘C’ or AIM-listed companies.
Please see the Fund Performance page for more detail.